An informatics search for the low-molecular weight chromium-binding peptide

BMC Chemical Biology

Volumn 4, Issue , 2004, Pages

  Dinakarpandian, Deendayal ^a   Morrissette, Vincent ^a   Chaudhary, Shveta ^a   Amini, Kambiz ^a   Bennett, Brian ^b   Van Horn, J David ^a  

^a UNIVERSITY OF MISSOURI KANSAS CITY   (United States)

^b MEDICAL COLLEGE OF WISCONSIN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

A DISINTEGRIN AND METALLOPROTEINASE 19; ASPARTYLGLYCYLGLUTAMYLGLUTAMYLCYSTEINYLASPARTYLCYSTEINYLGLYCYLGLUTAMYLGLUTAMIC ACID; BINDING PROTEIN; CHROMIUM BINDING PEPTIDE; CYSTEINYLGLUTAMYLGLYCYLGLYCYLCYSTEINYLGLUTAMYLGLUTAMYLASPARTYLASPARTYLGLUTAMIC ACID; GLUTAMYLASPARTYLGLYCYLGLUTAMYLGLUTAMYLCYSTEINYLASPARTYLCYSTEINYLGLYCYLGLUTAMIC ACID; INSULIN; INSULIN RECEPTOR; METAL COMPLEX; METALLOPROTEINASE; PEPTIDE DERIVATIVE; PROTEIN KINASE; UNCLASSIFIED DRUG;

ALPHA CHAIN; AMINO ACID SEQUENCE; ARTICLE; CONTROLLED STUDY; DATA BASE; GENOMICS; HUMAN; INFORMATION SCIENCE; MOLECULAR WEIGHT; NONHUMAN; PROTEIN BINDING; RICE; SEQUENCE ANALYSIS; SIGNAL TRANSDUCTION; STOICHIOMETRY;

BOVINAE; ORYZA SATIVA;

EID: 12344254182     PISSN: 14726769     EISSN: None     Source Type: Journal    
DOI: 10.1186/1472-6769-4-2     Document Type: Article

References (34)

1. White MF: Insulin signaling in health and disease. Science 2003, 302:1710-1711.
2. Amos AF, McCarty DJ, Zimmet P: The rising global burden of diabetes and its complications: estimates and projections by 2010. Diabet Med 1997, 14:S5-S85.
3. King H, Aubert RE, Herman WH: Global Burden of Diabetes, 1995-2025. Prevelence, numerical estimates and projections. Diabetes Care 1998, 21:1414-1431.
4. Kopelman PG, Hitman GA: Diabetes. Exploding Type II. Lancet 1998, 352(Suppl 4):SIV5.
5. Moller DE: New drug targets for type 2 diabetes and the metabolic syndrome. Nature 2001, 414:821-827.
6. Patti ME, Sun XJ, Bruening JC, Araki E, Lipes MA, White MF, Kahn CR: 4/PS/Insulin Receptor Substrate (IRS)-2 Is the Alternative Substrate of the Insulin Receptor in IRS-1-deficient Mice. J Biol Chem 1995, 270:24670-24673.
7. Pender C, Goldfine ID, Manchem VP, Evans JL, Spevak WR, Shi S, Rao S, Bajjalieh S, Maddux BA, Youngren JF: Regulation of Insulin Receptor Function by a Small Molecule Insulin Receptor Activator. J Biol Chem 2002, 277:43565-43571.
8. Lee YH, White MF: Insulin receptor substrate proteins and diabetes. Arch Pharm Res 2004, 27:361-370.
9. Levina A, Codd R, Dillon CT, Lay PA: Chromium in biology: Toxicology and Nutritional Aspects. Prog Inorg Chem 2002, 51:145-250.
10. Stearns DM: Is chromium a Trace essential metal? Biofactors 2000, 11:149-162.
11. Codd R, Dillon CT, Levina A, Lay PA: Studies on the Genotoxicity of Chromium: From the Test Tube to the Cell. Coord Chem Rev 2001, 216-217:537-582.
12. Mertz W, Toepfer EW, Roginski EE, Polansky MM: Present knowledge of the role of chromium. Fed Proc 1974, 33:2275-2280.
13. Mertz W: Effects and Metabolism of Glucose Tolerance Factor. Nut Rev 1975, 33:129-135.
14. Mertz W: The Essential Trace Elements. Science 1981, 213:1332-1338.
15. Anderson RA: Chromium, Glucose Intolerance and Diabetes. J Am Coll Nutr 1998, 17:548-555.
16. Davis CM, Vincent JB: Chromium Oligopeptide Activates Insulin Receptor Tyrosine Kinase Activity. Biochemistry 1997, 36:4382-4385.
17. Davis CM, Vincent JB: Chromium in Carbohydrate and Lipid Metabolism. J Biol Inorg Chem 1997, 2:675-679.
18. Vincent JB: Elucidating a Biological Role for Chromium at a Molecular Level. Acc Chem Res 2000, 33:503-510.
19. Wada O, Wu GY, Yamamoto A, Manabe S, Ono T: Purification and Chromium-Excretory Function of Low-Molecular-Weight, Chromium-Binding Substances from Dog Liver. Environ Res 1983, 32:228-239.
20. Yamamoto A, Wada O, Ono T: Distribution and Chromium-Binding Capacity of a Low-Molecular-Weight, Chromium-Binding Substance in Mice. J Inorg Biochem 1984, 22:91-102.
21. Yamamoto A, Wada O, Ono T: Isolation of a Biologically Active Low-molecular-mass Chromium Compound from Rabbit Liver. Eur J Biochem 1987, 165:627-631.
22. Yamamoto A, Wada O, Suzuki H: Purification and Properties of Biologically Active Chromium Complex from Bovine Colostrum. J Nutr 1988, 118:39-45.
23. Yamamoto A, Wada O, Manabe S: Evidence that Chromium is an Essential Factor for the Biological Activity of Low-molecular-weight, Chromium-binding Substance. Biochem Biophys Res Comm 1989, 163:189-193.
24. Davis CM, Vincent JB: Isolation and Characterization of a Biologically Active Chromium Oligopeptide from Bovine Liver. Arch Biochem Biophys 1997, 339:335-343.
25. Gayatri R, Rajaram R, Rajaram A, Govindaraju K, Rao JR, Nair BU, Ramasami T: Chromium induced structural changes in biomolecules. Proc Indian Acad Sci (Chem Sci) 1997, 109:307-317.
26. Gayatri R, Rajaram R, Nair BU, Chandrasekaran F, Ramasami T: Chromium-induced molecular assemblies and long range ordering in collagenous tissues: A conceptual insight into chromium tanning. Proc Indian Acad Sci (Chem Sci) 1999, 111:133-145.
27. Kurohara K, Matsuda Y, Nagabukuro A, Tsuji A, Amagasa T, Fujisawa-Sehara A: Meltrin b (ADAM19) gene: cloning, mapping, and analysis of the regulatory region. Biochem Biophys Res Comm 2000, 270:522-527.
28. White M: Insulin Signaling Pathway. Science's STKE (Connections Map, as seen October 2004) [http://stke.sciencemag.org/cgi/cm/stkecm;CMP_12069].
29. Altschul SF, Madden TL, Schaffer AA, Zhang J, Zhang Z, Miller W, Lipman DJ: Gapped BLAST and PSI-BLAST: A new generation of protein database search programs. Nucleic Acids Res 1997, 25:3389-3402.
30. Garrett TP, McKern NM, Lou M, Frenkel MJ, Bentley JD, Lovrecz GO, Elleman TC, Cosgrove LJ, Ward CW: Crystal structure of the first three domains of the type-1 insulin-like growth factor receptor. Nature 1998, 394:395-399.
31. Ward CW, Garrett TP, McKern NM, Lou M, Cosgrove LJ, Sparrow LG, Frenkel MJ, Hoyne PA, Elleman TC, Adams TE, Lovrecz GO, Lawrence LJ, Tulloch PA: The three dimensional structure of the type I insulin-like growth factor receptor. Mol Pathol 2001, 54:125-132.
32. Jacquamet L, Sun YJ, Hatfield J, Gu WW, Cramer SP, Crowder MW, Lorigan GA, Vincent JB, Latour JM: Characterization of chromodulin by X-ray absorption and electron paramagnetic resonance spectroscopies and magnetic susceptibility measurements. J Am Chem Soc 2003, 125:774-780.
33. Mulyani I, Levina A, Lay PA: Biomimetic Oxidation of Chromium(III): Does the Antidiabetic Activity of Chromium(III) Involve Carcinogenic Chromium(VI)? Angew Chem Int Ed Engl 2004, 43:4504-4507.
34. Di Guglielmo GM, Drake PG, Baass PC, Authier F, Posner BI, Bergeron JJ: Insulin receptor internalization and signalling. Mol Cell Biochem 1998, 182:59-63.